Language: English
Gender: Male
1.
Pediatric Hematology/Oncology
525 East 68th Street, Payson-695
New York, NY 10065
P: (212) 746-3400 | F: (212) 746-8609
Call for appointment
(212) 746-3400

Personal Statement

Named one of New York Magazine's Best Doctors, 2012
Named one of New York's Super Doctors, 2012


View Biography

Specialties/Expertise

Board Certifications
  • Pediatric Hematology-Oncology
  • Pediatrics
Specialties
  • Pediatric Hematology-Oncology
Expertise
  • Platelet Disorder
  • Idiopathic Thrombocytopenic Purpura

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • AETNA [PPO]
  • AETNA [Medicare]
  • AETNA [HMO]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Empire Blue Cross/Blue Shield HealthPlus
  • Empire Empire Blue Cross/Blue Shield HealthPlus [CHP]
  • Fidelis Care
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Medicaid
  • Medicare
  • Oscar
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Metro (Effective 1/1/2016)]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Freedom]
  • Oxford Health Plans [Charter]
  • Oxford Health Plans [Core]
  • POMCO
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • United Health Care
  • VNSNY CHOICE Medicare [HMO]

Education/Training

  • M.D., Columbia University College of Physicians and Surgeons, 1975

Honors and Awards

HONORS AND AWARDS

  1. Voted one of New York Magazine's Best Doctors, 2008-2012
  2. Voted one of New York City's Super Doctors in Pediatrics, 2009-2012
  3. Voted one of Castle Connolly's America's Top Doctors, 2007
  4. Voted one of Castle Connolly's America's Top Doctors, 2003
  5. Who's Who in America 2007
  6. Speaker, The Henry Kunkel Society 11th Meeting, Kunkel Society Symposium, Rockefeller University, New York, New York, 2003
  7. Selection as 1 of 15 representatives of American Society of Hematology for SPARKII, 2003
  8. Abstract Reviewer for ASH Platelet Section, 2003
  9. Chairman, Corporate Symposium on ITP at ASH (Super Friday), 2003
  10. Voted one of New York Magazine's Best Doctors, 2003
  11. Voted one of New York Magazine's Best Doctors, 2002
  12. Voted one of Castle Connolly's America's Top Doctors, 2002
  13. Chairman, Corporate Symposium on ITP at ASH (Super Friday), 2002
  14. Voted one of New York Magazine's Best Doctors, 2001
  15. Voted one of Castle Connolly's America's Top Doctors, 2001
  16. Abstract Reviewer for ASH Platelet Section, 2001
  17. Chairman, Corporate Symposium on ITP at ASH (Super Friday), 2001
  18. Abstract Reviewer for ASH Platelet Section, 2000
  19. Chair, Education Session on Platelets at ASH, 2000
  20. Chairman, Corporate Symposium on ITP at ASH (Super Friday), 2000
  21. Chairman, Corporate Symposium on ITP at ASH (Super Friday), 1999
  22. Chairman of ITP Meeting to Discuss Splenectomy Sparing Strategy, Boca Raton, Florida, 1998
  23. Alpha Award of the American Blood Resources Association for Contributions in Immunohematology, 1998
  24. 22nd Ratnoff Professor of Hematology at Case Western, 2008

Biography

Titles

Attending Pediatrician
NewYork-Presbyterian Hospital

Professor of Pediatrics
Weill Cornell Medical College, Cornell University

Professor of Pediatrics in Medicine
Weill Cornell Medical College, Cornell University

Biography

Dr. James Bussel received his medical degree (M.D.) from Columbia University's College of Physicians and Surgeons after completing a B.S. at Yale University.  He completed his residency in pediatrics at Cincinnati Children's Hospital in Ohio, returning to New York City to undertake a joint fellowship in Pediatric Hematology/Oncology at Memorial Sloan-Kettering Cancer Center and NewYork-Presbyterian Hospital where he was chief fellow in 1980-81.   He is board certified in Pediatrics and in Pediatric Hematology/Oncology.
 
Research
 
In 1981, the Platelet Disorders Center initiated the first studies of intravenous gammaglobulin in the treatment of ITP in the United States. This was followed by studies in ITP with IV anti-D (Winrho) beginning in 1987, rituximab in 2000, and the newly licensed thrombopoietic agents in 2002.   More than two hundred publications on ITP in children and adults have followed, including six first or second authored articles in the New England Journal of Medicine and two in the Lancet. In 2003, Dr. Bussel was selected as one of 5 representatives of the American Society of Hematology (SPARKII) to meet with representatives of the NIH to plan research directions in hematology for the future.

Adults have worse ITP than do children. Therefore, trials and studies at the center have increasingly included them with the first publication on the treatment of adults in 1983. The center is the country's and the world's leader in clinical trials of refractory ITP in exploring novel agents including those that modulate the immune system.
 
Another area of Dr. Bussel's special expertise is the treatment of fetuses affected by alloimmune thrombocytopenia. This is a platelet incompatibility between the parents that affects the fetus. Treatment can be given during the pregnancy to the mother to increase the platelet count in the fetus, prevent a fetal brain hemorrhage, and allow for a healthy baby to be born whose thrombocytopenia will then disappear within weeks.